Skip to main content
James DeCaprio, MD, Oncology, Boston, MA, Dana-Farber Cancer Institute

JamesADeCaprioMD

Oncology Boston, MA

Associate Professor of Medicine, Dana-Farber Cancer Institute

Dr. DeCaprio is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. DeCaprio's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1986 - 1989
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1984 - 1986
  • Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
    Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1984

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1987 - 2025
  • IL State Medical License
    IL State Medical License 1984 - 1987
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1998

Publications & Presentations

PubMed

Journal Articles

  • The Biology and Treatment of Merkel Cell Carcinoma: Current Understanding and Research Priorities  
    Kelly L Harms, Isaac Brownell, Paul W Harms, James A DeCaprio, Nature

Press Mentions

  • In Memoriam: David Morse Livingston, MD, Renowned Scientist and Esteemed Mentor
    In Memoriam: David Morse Livingston, MD, Renowned Scientist and Esteemed MentorOctober 19th, 2021
  • The Ragon Institute of MGH, MIT and Harvard Receives Gift from Nancy Zimmerman to Help Fund Development of Early Response COVID-19 Diagnostic
    The Ragon Institute of MGH, MIT and Harvard Receives Gift from Nancy Zimmerman to Help Fund Development of Early Response COVID-19 DiagnosticMarch 30th, 2020
  • SCFFBW7-Mediated Degradation of Brg1 Suppresses Gastric Cancer Metastasis
    SCFFBW7-Mediated Degradation of Brg1 Suppresses Gastric Cancer MetastasisSeptember 3rd, 2018

Grant Support

  • SV40 Large T And RB Effects On E2F Dependent GenesNational Cancer Institute2009–2012
  • Rb-Related Proteins In SV40T TransformationNational Cancer Institute2008–2012
  • Interaction Between SV40 Large T And P185 CullinNational Cancer Institute2002–2011
  • PDAC Antibody CoreNational Cancer Institute2007–2010
  • Core - Monoclonal AntibodyNational Cancer Institute2006–2010
  • SV40 Large T Antigen Interference With DNA Damage CheckpointsNational Cancer Institute2004–2008
  • Monoclonal Antibody And Associated Protein FacilityNational Cancer Institute2004–2008
  • Rb-Related Proteins In SV40 T TransformationNational Cancer Institute2003–2007
  • Core D: PDAC Antibody CoreNational Cancer Institute2006
  • Cellular Proliferation And N-Terminus Of SV40 Large T AntigenNational Cancer Institute1999–2002
  • Rb-Related Proteins And SV40 T TransformationNational Cancer Institute1997–2002
  • Core--Monoclonal AntibodyNational Cancer Institute1997–2002
  • RB Related Proteins In Sv4ot And E1A TransformationNational Cancer Institute1996
  • Rb-Related Proteins In Sv4ot And E1A TransformationNational Cancer Institute1994–1996
  • Controlled Regulation Of SV40 T AG SynthesisNational Cancer Institute1988–1992

Hospital Affiliations